XML 88 R74.htm IDEA: XBRL DOCUMENT v3.23.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,015,541   $ 2,015,541   $ 1,719,783
Total assets 4,732,988   4,732,988   4,198,142
Current liabilities 1,394,093   1,394,093   1,108,119
Total liabilities 2,484,888   2,484,888   2,102,207
Total joint venture equity 2,172,736   2,172,736   2,043,570
Investments in and advances to unconsolidated joint ventures 164,858   164,858   107,425
Revenue 1,418,571 $ 1,134,370 3,948,523 $ 3,092,160  
Costs 1,124,305 872,423 3,109,713 2,388,095  
Net income attributable to Parsons Corporation 47,447 29,571 116,241 68,533  
Equity in (losses) earnings of unconsolidated joint ventures 10,262 (974) 4,497 10,237  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,513,825   1,513,825   1,610,246
Noncurrent assets 481,708   481,708   491,658
Total assets 1,995,533   1,995,533   2,101,904
Current liabilities 960,276   960,276   1,255,297
Noncurrent liabilities 503,705   503,705   468,056
Total liabilities 1,463,981   1,463,981   1,723,353
Total joint venture equity 531,552   531,552   378,551
Investments in and advances to unconsolidated joint ventures 164,858   164,858   $ 107,425
Revenue 634,937 782,880 1,514,561 1,762,420  
Costs 581,041 774,030 1,474,991 1,711,555  
Net income attributable to Parsons Corporation 53,896 8,850 39,570 50,865  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in (losses) earnings of unconsolidated joint ventures $ 10,262 $ (974) $ 4,497 $ 10,237